Phase II study of neoadjuvant 5-FU [fluorouracil] + leucovorin [folinic acid] + CPT-11 [irinotecan] in patients with resectable liver metastases from colorectal adenocarcinoma.
Phase of Trial: Phase II
Latest Information Update: 08 Jul 2015
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Irinotecan (Primary)
- Indications Cancer metastases; Colorectal cancer
- Focus Therapeutic Use
- 18 Jan 2012 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
- 18 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Nov 2005 New trial record.